Model consortium agreement that describes different types of access rights. All project partners must sign a consortium agreement defining the rights and obligations of participants and addressing issues such as governance, liability and intellectual property rights. The agreement should be tailored to the needs of each project. A model developed by EFPIA shows what a consortium agreement might look like. Consortia can also use alternative models if they wish. Do you need more information on how to prepare and sign grants? Watch this Horizon 2020 webiner for successful proposal coordinators. The European Commission`s seventh framework programme contributes EUR 1 billion to the IMI research programme. This amount amounts to at least one billion euros in in kind contributions from pharmaceutical companies that are members of EFPIA, the European Association of Pharmaceutical Industries and Associations. If you want to receive a document, you can send a request to IMI. Applications are processed in accordance with the provisions of Regulation (EC) No. 1049/2001 of the European Parliament and the Council on Public Access to European Parliament, Council and Commission Documents and the IMI-GB-036-24092008 Decision of the IMI Board implementing Regulation 1049/2001.
The TransQST project is funded by the Innovation Medicines Initiative (IMI), a large-scale public-private partnership between the European Union and EFPIA. Starting in 2015, the latest version of annual science priorities is included in the latest update to the annual work plan. Please include your name, first name and address. In order to facilitate the identification of the requested document, we recommend that you formulate your request as clearly and accurately as possible. Requests can be sent by email, fax or mail. Please consult the imi2 JU Annotated Model Grant Agreement, which defines the specifics of the IMI2 public-private partnership and helps candidates and participants understand and interpret the provisions of the IMI2 SUBVENTION Standard Agreement. Participating research consortia include, in addition to large biopharmaceutical companies, small and medium-sized enterprises, patient associations, universities and other research institutes, hospitals and governments. Coordination and Support Actions – Step 1 – Submission of Brief Proposals If you need access to information about IMI`s work that is not available on the site, this is not part of an IMI document, Send your request to: infodesk at imi.europa.eu More information: www.imi.europa.eu EFPIA: www.efpia.eu European Commission Research and Innovation: ec.europa.eu/research/index.cfm Annual Work Plan 2018 (as amended by the IMI Board of Directors on 5 December 2018) This page contains all the documents relating to calls for proposals and projects launched under the IMI2 programme.